Orgenesis Inc. Reports Board and Officer Changes

Ticker: ORGS · Form: 8-K · Filed: Dec 27, 2024 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateDec 27, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, management-change

TL;DR

Orgenesis Inc. shuffled its board and execs on 12/24/24. New faces, new pay.

AI Summary

Orgenesis Inc. announced on December 24, 2024, changes in its board of directors and executive compensation. Specifically, the company elected new directors and appointed new officers, alongside adjustments to their compensatory arrangements. The filing details these changes as part of its regular corporate governance updates.

Why It Matters

Changes in a company's board and executive team can signal shifts in strategy or operational focus, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance changes, such as director elections and executive appointments, with no immediate financial implications disclosed.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the election of directors, but the specific names and details of the changes are not provided in this summary.

Were there any new officer appointments?

Yes, the filing states the appointment of certain officers as part of the reported events.

What is the date of the earliest event reported in this 8-K?

The earliest event reported is dated December 24, 2024.

In which state is Orgenesis Inc. incorporated?

Orgenesis Inc. is incorporated in Nevada.

What is the address of Orgenesis Inc.'s principal executive offices?

The principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.

Filing Stats: 573 words · 2 min read · ~2 pages · Grade level 12.9 · Accepted 2024-12-27 16:30:29

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: December 26, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing